Thieno[2,3-b]Pyridine Derivative Targets Epithelial, Mesenchymal and Hybrid CD15s+ Breast Cancer Cells

Autor: Sandra Marijan, Angela Mastelić, Anita Markotić, Nikolina Režić-Mužinić, Nikolina Vučenović, David Barker, Lisa I. Pilkington, Jóhannes Reynisson, Vedrana Čikeš Čulić

Publikováno v: Medicines, Vol 8, Iss 7, p 32 (2021)

The adhesion of cancer cells to vascular endothelium is a critical process in hematogenous metastasis and might be similar to the recruitment of leukocytes at the site of inflammation. It is mediated by E-selectin and its ligands, of which the most s

Externí odkaz: https://doaj.org/article/4f274cb2505b4b368950015e472466b4

Thieno[2,3- b ]Pyridine Derivative Targets Epithelial, Mesenchymal and Hybrid CD15s ⁺ Breast Cancer Cells.

Autor: Marijan S; Department of Medical Chemistry and Biochemistry, University of Split School of Medicine, 21000 Split, Croatia., Mastelić A; Department of Medical Chemistry and Biochemistry, University of Split School of Medicine, 21000 Split, Croatia., Markotić A; Department of Medical Chemistry and Biochemistry, University of Split School of Medicine, 21000 Split, Croatia., Režić-Mužinić N; Department of Medical Chemistry and Biochemistry, University of Split School of Medicine, 21000 Split, Croatia., Vučenović N; Department of Medical Chemistry and Biochemistry, University of Split School of Medicine, 21000 Split, Croatia., Barker D; School of Chemical Sciences, The University of Auckland, Auckland 1010, New Zealand.; MacDiarmid Institute for Advanced Materials and Nanotechnology, Wellington 6140, New Zealand., Pilkington LI; School of Chemical Sciences, The University of Auckland, Auckland 1010, New Zealand., Reynisson J; School of Pharmacy and Bioengineering, Keele University, Staffordshire ST5 5BG, UK., Čulić VČ; Department of Medical Chemistry and Biochemistry, University of Split School of Medicine, 21000 Split, Croatia.

Publikováno v: Medicines (Basel, Switzerland) [Medicines (Basel)] 2021 Jun 22; Vol. 8 (7). Date of Electronic Publication: 2021 Jun 22.